Alamar Capital Management LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 1st quarter, Holdings Channel reports. The fund purchased 8,423 shares of the company’s stock, valued at approximately $3,986,000. HCA Healthcare accounts for approximately 2.4% of Alamar Capital Management LLC’s investment portfolio, making the stock its 8th biggest holding.
Several other institutional investors have also recently modified their holdings of the stock. Palisade Asset Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter valued at $26,000. Ares Financial Consulting LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at $31,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the 1st quarter worth about $33,000. JPL Wealth Management LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at about $33,000. Finally, MCF Advisors LLC grew its holdings in shares of HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.
HCA Healthcare Stock Down 0.1%
HCA opened at $372.58 on Thursday. The firm has a market capitalization of $82.65 billion, a P/E ratio of 12.81, a P/E/G ratio of 1.26 and a beta of 1.12. The firm’s 50 day moving average is $388.88 and its 200-day moving average is $454.89. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.
HCA Healthcare Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the stock. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 14th. JPMorgan Chase & Co. lowered their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Truist Financial set a $413.00 target price on HCA Healthcare in a research report on Thursday, June 4th. Stephens lowered their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 7th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $483.45.
Read Our Latest Stock Analysis on HCA
Key Stories Impacting HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Negative Sentiment: Multiple plaintiff law firms have launched investigations into HCA Healthcare over possible securities-law violations, increasing headline risk and investor uncertainty. HCA Healthcare, Inc. Investigated by the Portnoy Law Firm
- Negative Sentiment: Bragar Eagel & Squire is also investigating HCA on behalf of stockholders, adding to the cluster of legal inquiries that could pressure the shares. HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc.
- Negative Sentiment: Pomerantz LLP has opened a similar investigation, reinforcing concerns that the stock could face further legal scrutiny. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
- Negative Sentiment: Kessler Topaz Meltzer & Check is likewise investigating HCA for potential federal securities-law violations, adding to the negative legal backdrop. NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. Investors to Contact the Firm
- Neutral Sentiment: HCA Florida Lake Monroe Hospital welcomed 29 new resident physicians, a routine operational update that is unlikely to move the stock on its own. HCA Florida Lake Monroe Hospital welcomes 29 new resident physicians
- Neutral Sentiment: HCA also highlighted leadership and project updates at several facilities, including promotions and new CMO appointments, which are more operational than market-moving. HCA Florida promotes CEO of 2 hospitals Arabinda Pani joins HCA Houston Healthcare Kingwood as CMO Think big: HCA rep. updates Rotary on Long Pt. ER and other projects
- Negative Sentiment: An HCA Georgia hospital paused most services amid flooding, which could create near-term operational disruption and reputational concerns. HCA Georgia hospital pauses most services amid flooding
- Neutral Sentiment: A story on HCA’s enterprise AI strategy was largely informational and highlights longer-term efficiency efforts rather than an immediate earnings catalyst. How HCA Healthcare built its enterprise AI strategy
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
